Lie Dai

2.7k total citations
118 papers, 1.5k citations indexed

About

Lie Dai is a scholar working on Rheumatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Lie Dai has authored 118 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Rheumatology, 23 papers in Epidemiology and 21 papers in Molecular Biology. Recurrent topics in Lie Dai's work include Rheumatoid Arthritis Research and Therapies (48 papers), Systemic Lupus Erythematosus Research (17 papers) and Autoimmune and Inflammatory Disorders Research (12 papers). Lie Dai is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (48 papers), Systemic Lupus Erythematosus Research (17 papers) and Autoimmune and Inflammatory Disorders Research (12 papers). Lie Dai collaborates with scholars based in China, United States and Germany. Lie Dai's co-authors include Ying‐Qian Mo, Jian‐Da Ma, Dong-Hui Zheng, Le‐Feng Chen, H. Ralph Schumacher, Jun Jing, Frank Peßler, Cèsar Díaz‐Torné, Eugene Einhorn and Frank Pessler and has published in prestigious journals such as Nature Communications, PLoS ONE and Kidney International.

In The Last Decade

Lie Dai

104 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lie Dai China 21 722 393 251 231 201 118 1.5k
Hiroaki Dobashi Japan 22 374 0.5× 270 0.7× 290 1.2× 259 1.1× 215 1.1× 146 1.6k
Joong Kyong Ahn South Korea 21 507 0.7× 314 0.8× 122 0.5× 240 1.0× 109 0.5× 75 1.2k
Zhongping Zhan China 25 700 1.0× 449 1.1× 169 0.7× 431 1.9× 153 0.8× 70 1.6k
Zongwen Shuai China 19 339 0.5× 446 1.1× 181 0.7× 388 1.7× 100 0.5× 81 1.5k
Wen‐Chan Tsai Taiwan 20 514 0.7× 248 0.6× 135 0.5× 466 2.0× 171 0.9× 82 1.3k
Yujin Ye China 22 503 0.7× 412 1.0× 128 0.5× 312 1.4× 167 0.8× 42 1.3k
Huaxiang Wu China 18 478 0.7× 266 0.7× 108 0.4× 252 1.1× 75 0.4× 70 1.0k
Mihir D. Wechalekar Australia 22 672 0.9× 269 0.7× 86 0.3× 358 1.5× 148 0.7× 60 1.4k
Wenfeng Tan China 25 440 0.6× 508 1.3× 226 0.9× 385 1.7× 261 1.3× 73 1.4k
Luis H. Silveira United States 20 762 1.1× 187 0.5× 178 0.7× 329 1.4× 83 0.4× 48 1.4k

Countries citing papers authored by Lie Dai

Since Specialization
Citations

This map shows the geographic impact of Lie Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lie Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lie Dai more than expected).

Fields of papers citing papers by Lie Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lie Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lie Dai. The network helps show where Lie Dai may publish in the future.

Co-authorship network of co-authors of Lie Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Lie Dai. A scholar is included among the top collaborators of Lie Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lie Dai. Lie Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Liang, Lie Dai, Hao Sun, & Linlin Li. (2025). IL-38 attenuates renal ischemia/reperfusion injury through suppressinginflammation in mice. Cellular and Molecular Biology. 71(1). 39–43. 1 indexed citations
2.
3.
4.
Chen, Yu, Cong Ye, Pingting Yang, et al.. (2025). Thalidomide can effectively prevent relapse in IgG4-related disease outweighing its side effects: a multicentre, randomised, double-blinded, placebo-controlled study. Annals of the Rheumatic Diseases. 84(7). 1246–1252. 4 indexed citations
5.
Li, Qianhua, Jian‐Da Ma, Jing‐Wei Gao, et al.. (2024). Association of serum concentrations of remnant cholesterol with incident cardiovascular disease in patients with rheumatoid arthritis: A real-world data from 2001 to 2022. International Journal of Cardiology. 405. 131947–131947. 2 indexed citations
6.
Liu, Dongzhou, Jingyang Li, Huaxiang Wu, et al.. (2024). Rapid and Sustained Effect of Ixekizumab on Patient Global, Spinal Pain, Stiffness, and Fatigue in Chinese Patients with Radiographic Axial Spondyloarthritis. Rheumatology and Therapy. 11(4). 1011–1022. 1 indexed citations
7.
Pan, Jie, Jian‐Da Ma, Ying Yang, et al.. (2024). Cross-sectional associations of low body mass index and being underweight with joint damage in Chinese patients with rheumatoid arthritis. Rheumatology Advances in Practice. 8(3). rkae080–rkae080.
8.
Li, Qianhua, et al.. (2023). Rheumatoid arthritis with pulmonary accelerated rheumatoid nodules treated by baricitinib: a case-based review. Clinical Rheumatology. 43(2). 775–784. 2 indexed citations
9.
Xue, Ying, Jian Hu, Huaxiang Wu, et al.. (2023). AB0968 RAPID ONSET OF EFFICACY IN CHINESE PATIENTS WITH ACTIVE RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS TREATED WITH IXEKIZUMAB: A PHASE 3 STUDY. Annals of the Rheumatic Diseases. 82. 1703–1703. 1 indexed citations
10.
Jia, Pu, Jinhua Pan, Yang Zou, et al.. (2023). AB0319 HIGH PREVALENCE OF HYPOALBUMINEMIA IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS. 1343.2–1343.
11.
Ruan, Guangfeng, Shiwen Yuan, Ying‐Qian Mo, et al.. (2022). Can metformin relieve tibiofemoral cartilage volume loss and knee symptoms in overweight knee osteoarthritis patients? Study protocol for a randomized, double-blind, and placebo-controlled trial. BMC Musculoskeletal Disorders. 23(1). 486–486. 8 indexed citations
12.
13.
Sun, Yu, Xinli Qu, Victor Howard, et al.. (2015). Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance. Kidney International. 88(2). 286–298. 44 indexed citations
14.
Qu, Xinli, Mengjie Jiang, Yu Sun, et al.. (2015). The Smad3/Smad4/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction. Kidney International. 88(6). 1323–1335. 17 indexed citations
15.
Ma, Jian‐Da, Dong-Hui Zheng, Ying‐Qian Mo, et al.. (2015). Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study. Arthritis Research & Therapy. 17(1). 289–289. 35 indexed citations
16.
Peßler, Frank, Alexis Ogdie, Christian T. Mayer, et al.. (2013). Amyloid arthropathy associated with multiple myeloma: polyarthritis without synovial infiltration of CD20+ or CD38+ cells. Amyloid. 21(1). 28–34. 9 indexed citations
17.
Schumacher, H. Ralph, et al.. (2011). Development and Evaluation of a Survey of Gout Patients Concerning Their Knowledge About Gout. JCR Journal of Clinical Rheumatology. 17(5). 242–248. 28 indexed citations
18.
Peßler, Frank, et al.. (2005). The spectrum of renal tubular acidosis in paediatric Sjogren syndrome. Lara D. Veeken. 45(1). 85–91. 38 indexed citations
19.
Dai, Lie. (2004). The efficacy and safety of lornoxicam in treatment of rheumatoid arthritis and osteoarthritis. Chinese New Drugs Journal. 2 indexed citations
20.
Dai, Lie. (2000). Expression of TGFβ_1 in rheumatoid synovia and its relationship with synovial pathological changes. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroaki Dobashi Breakdown of academic impact, for papers by Joong Kyong Ahn Breakdown of academic impact, for papers by Zhongping Zhan Breakdown of academic impact, for papers by Zongwen Shuai Breakdown of academic impact, for papers by Wen‐Chan Tsai Breakdown of academic impact, for papers by Yujin Ye Breakdown of academic impact, for papers by Huaxiang Wu Breakdown of academic impact, for papers by Mihir D. Wechalekar Breakdown of academic impact, for papers by Wenfeng Tan Breakdown of academic impact, for papers by Luis H. Silveira
Rankless by CCL
2026